Black Diamond Therapeutics, Inc. (BDTX) vs Cumberland Pharmaceuticals Inc. (CPIX)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and Cumberland Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CPIX
Cumberland Pharmaceuticals Inc.
$7.09HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BDTX vs CPIX
growth of $100 · dividends reinvested · last 7yBDTX -95.1% (-35.0%/yr)CPIX +73.2% (+8.2%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
BDTX CPIX
BDTX vs CPIX: by the numbers
- •BDTX is the larger company ($111M vs $106M market cap).
- •BDTX is profitable (31.95% net margin) while CPIX runs a net loss (-33.92%).
- •CPIX pays a dividend (21.16% yield), while BDTX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BDTX | CPIX |
|---|---|---|
| P/S ratio | N/A | 3.40 |
| P/B ratio | 1.16 | 6.09 |
Profitability
| Metric | BDTX | CPIX |
|---|---|---|
| Gross margin | 99.54% | 83.37% |
| Operating margin | 28.39% | -6.27% |
| Net margin | 31.95% | -33.92% |
| ROE | -44.29% | -60.82% |
| ROIC | -47.54% | -34.77% |
Dividends
| Metric | BDTX | CPIX |
|---|---|---|
| Dividend yield | N/A | 21.16% |
Growth (annualized)
| Metric | BDTX | CPIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.53% |
| Total return CAGR (5Y) | -24.47% | 25.62% |
Frequently asked
- Does BDTX or CPIX pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while BDTX has no payments in the available dividend history.
- Is BDTX or CPIX more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus CPIX at -33.92%.
- How have BDTX and CPIX total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and CPIX delivered 25.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldBlack Diamond Therapeutics ROECumberland Pharmaceuticals ROEBlack Diamond Therapeutics operating marginCumberland Pharmaceuticals operating marginBlack Diamond Therapeutics revenue growthCumberland Pharmaceuticals revenue growthBlack Diamond Therapeutics free cash flowCumberland Pharmaceuticals free cash flow
Black Diamond Therapeutics & Cumberland Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.